In fact, we highly recommend it
![semaglutide gastric stasis class action in kentucky ileus legal team lawsuit Ozempic Lawsuit Settlement Amounts [2026 Projections] glp-1 bowel obstruction law firm glp-1 gastric stasis legal team](https://cf.cdn.uplynk.com/ausw2/slices/03f/53c3dfd52290407986694c1471cfa82a/03f8ce2325c34ceca40ee97e7f928b86/poster_caa9af49d2ea40329c7d7a494f1cc621.png)
2-9 They do this by: Building confidence and self-efficacy by empowering patients to actively engage with their treatment journey Educating patients to address the widespread misconception that obesity is not a disease, with 40% of patients unaware of this and 80% feeling solely responsible for their condition Implementing a whole-health approach to redefine treatment success, focus on overall health outcomes, not just weight loss Setting realistic expectations which prepares patients for the possibility of losing less weight than expected while still achieving significant health benefits Supporting medication adherence by providing tools for reminders, routines, titration guidance, and addressing injection anxiety Driving medication persistence as a result of setting realistic expectations and frame treatment around long-term health gains rather than short-term weight loss Mitigating side effects through equipping patients to self-manage common side effects through proactive tracking and helping them connect the dots Want to learn even more about how digital solutions can unlock the full potential of GLP-1 therapies
![semaglutide gastric stasis class action in kentucky ileus legal team lawsuit Ozempic Lawsuit Settlement Amounts [2026 Projections] glp-1 bowel obstruction law firm glp-1 gastric stasis legal team](https://lookaside.instagram.com/seo/google_widget/crawler/?media_id=3881355309260804667)
Right now, get $100 off your first monthGLP-1 programs starting at just $99
Novo's amycretin (GLP-1 + amylin) has shown 2224% weight loss in early studies potentially a new benchmark if Phase 3 results confirm
Meditation is one of the longest-lasting therapies available in the treatment of fibromyalgia
A 503B-sourced product would be more tightly regulated but also typically more expensive, and 503Bs do not currently produce semaglutide or tirzepatide at scale for patient prescriptions